Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
82
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study

Gary T Ferguson1 Department of Medicine, Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USACorrespondence[email protected]
,
Tor Skärby2 BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0001-5426-4165
ORCID Icon,
Lars H Nordenmark2 BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0002-7139-8816
ORCID Icon,
Rosa Lamarca3 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain
,
Audrone Aksomaityte4 Statistics Department, Phastar, London, UK
,
Dan Lythgoe4 Statistics Department, Phastar, London, UKORCID Iconhttps://orcid.org/0000-0002-4682-772X
ORCID Icon,
Ileen Gilbert5 BioPharmaceuticals Medical – US, AstraZeneca LP, Wilmington, DE, USAORCID Iconhttps://orcid.org/0000-0003-3529-0186
ORCID Icon &
Frank Trudo5 BioPharmaceuticals Medical – US, AstraZeneca LP, Wilmington, DE, USA
 show all
Pages 3123-3134 | Published online: 27 Nov 2020

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD; 2020 Available from: https://goldcopd.org/. Accessed 611, 2020.
  • HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
  • PavordID, JonesPW, BurgelPR, RabeKF. Exacerbations of COPD. Int J COPD. 2016;11:21–30.
  • JinjuvadiaC, JinjuvadiaR, MandapakalaC, DurairajanN, LiangpunsakulS, SoubaniAO. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. COPD. 2017;14(1):72–79. doi:10.1080/15412555.2016.119966927419254
  • GuarascioAJ, RaySM, FinchCK, SelfTH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235–245.23818799
  • SatoM, ChubachiS, SasakiM, et al. Impact of mild exacerbation on COPD symptoms in a Japanese cohort. Int J COPD. 2016;11:1269–1278.
  • VijayasarathaK, StockleyRA. Reported and unreported exacerbations of COPD: analysis by diary cards. Chest. 2008;133(1):34–41. doi:10.1378/chest.07-169217989153
  • SeemungalTA, DonaldsonGC, BhowmikA, JeffriesDJ, WedzichaJA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi:10.1164/ajrccm.161.5.990802210806163
  • JonesPW, LamarcaR, ChuecosF, et al. Characterisation and impact of reported and unreported exacerbations: results from ATTAIN. Eur Respir J. 2014;44(5):1156–1165. doi:10.1183/09031936.0003881425234803
  • JonesPW, WatzH, WoutersEFM, CazzolaM. COPD: the patient perspective. Int J COPD. 2016;11(Special Issue 1st World Lung Disease Summit):13–20.
  • WilkinsonTM, DonaldsonGC, HurstJR, SeemungalTA, WedzichaJA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–1303. doi:10.1164/rccm.200310-1443OC14990395
  • FergusonGT, TashkinDP, SkarbyT, et al. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: the 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study. Respir Med. 2017;132:31–41. doi:10.1016/j.rmed.2017.09.00229229103
  • AnthonisenNR, ManfredaJ, WarrenCP, HershfieldES, HardingGK, NelsonNA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-1963492164
  • JansonC, LarssonK, LisspersKH, et al. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS). BMJ. 2013;346:f3306.23719639
  • CrinerGJ, ColeT, HahnKA, KastangoK, EudiconeJM, GilbertI. A feasibility study to examine real-world use of a daily digital chronic obstructive pulmonary disease (COPD) respiratory symptom tracker in a primary care setting. Presented at: American Thoracic Society International Conference; 2019; Dallas, TX, USA.
  • SuminoK, LockeER, MagzamenS, et al. Use of a remote inhaler monitoring device to measure change in inhaler use with chronic obstructive pulmonary disease exacerbations. J Aerosol Med Pulm Drug Deliv. 2018;31(3):191–198. doi:10.1089/jamp.2017.138329035120
  • BlakeyJD, BenderBG, DimaAL, WeinmanJ, SafiotiG, CostelloRW. Digital technologies and adherence in respiratory diseases: the road ahead. Eur Respir J. 2018;52(5):1801147. doi:10.1183/13993003.01147-201830409819

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.